Publications by authors named "Mark Witschi"

Claim this Profile
E
Early Introduction of Severe Acute Respiratory Syndrome Coronavirus 2 into Europe.
Sonja J Olsen, Meng-Yu Chen, Yu-Lun Liu, Mark Witschi, Alexis Ardoin

Emerg Infect Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regioselective silyl/acetate exchange of disaccharides yields advanced glycosyl donor and acceptor precursors.
Hsiao-Wu Hsieh, Matthew W Schombs, Mark A Witschi, Jacquelyn Gervay-Hague

J Org Chem· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methoxyethylamino-numonafide is an efficacious and minimally toxic amonafide derivative in murine models of human cancer.
Yanning Liu, John T Norton, Mark A Witschi, Qun Xu, Guohua Lou

Neoplasia· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective acetylation of per-O-TMS-protected monosaccharides.
Mark A Witschi, Jacquelyn Gervay-Hague

Org Lett· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral prophylaxis during pandemic influenza may increase drug resistance.
Martin Eichner, Markus Schwehm, Hans-Peter Duerr, Mark Witschi, Daniel Koch

BMC Infect Dis· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the effects of drug resistant influenza virus in a pandemic.
Stefan O Brockmann, Markus Schwehm, Hans-Peter Duerr, Mark Witschi, Daniel Koch

Virol J· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival of influenza virus on banknotes.
Yves Thomas, Guido Vogel, Werner Wunderli, Patricia Suter, Mark Witschi

Appl Environ Microbiol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publication and non-publication of clinical trials: longitudinal study of applications submitted to a research ethics committee.
Erik von Elm, Alexandra Röllin, Anette Blümle, Karin Huwiler, Mark Witschi

Swiss Med Wkly· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and anticancer activities of 6-amino amonafide derivatives.
John T Norton, Mark A Witschi, Lynn Luong, Akane Kawamura, Supurna Ghosh

Anticancer Drugs· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide nucleic acid microarrays made with (S,S)-trans-cyclopentane-constrained peptide nucleic acids.
Mark A Witschi, Jonathan K Pokorski, Daniel H Appella

Methods Enzymol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PNA-DNA duplexes, triplexes, and quadruplexes are stabilized with trans-cyclopentane units.
Ethan A Englund, Qun Xu, Mark A Witschi, Daniel H Appella

J Am Chem Soc· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(S,S)-trans-cyclopentane-constrained peptide nucleic acids. a general backbone modification that improves binding affinity and sequence specificity.
Jonathan K Pokorski, Mark A Witschi, Bethany L Purnell, Daniel H Appella

J Am Chem Soc· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cyclopentane conformational restraint for a peptide nucleic acid: design, asymmetric synthesis, and improved binding affinity to DNA and RNA.
Michael C Myers, Mark A Witschi, Nataliya V Larionova, John M Franck, Russell D Haynes

Org Lett· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis